EDN1 and angina pectoris: Some studies also noted that CDDP could influence biochemical markers, such as reducing high-sensitivity C-reactive protein and endothelin-1 while increasing nitric oxide (NO) levels.[22] Long-term observational studies have provided additional evidence of CDDP’s effectiveness in reducing the recurrence rate of angina attacks.